Publications

<

Year: 2024

Cost-Effectiveness of Foslevodopa/Foscarbidopa for the Treatment of Advanced Parkinson’s Disease With Severe Motor Fluctuations and Hyperkinesia or Dyskinesia in Greece

Dec 15, 2024

Published on: Value in Health
Authors: Charalampos Tzanetakos, George Papageorgiou, CH Yan , T Boodhna , E Leoncini , Petros Savourdos , George Gourzoulidis ,

Abstract:OBJECTIVES: To estimate the cost-effectiveness of foslevodopa/foscarbidopa, a 24-hour continuous subcutaneous infusion of levodopa-based therapy, compared to levodopa/carbidopa intestinal gel (LCIG), the most utilized device-aided therapy for the treatment of...

Read More

Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece

Nov 11, 2024

Published on: Vaccines
Authors: George Gourzoulidis , Charalampos Tzanetakos , Argyro Solakidi , Eleftherios Markatis, Marios Detsis , Diana Mendes , Myrto Barmpouni, ,

Abstract Background/Objectives: To evaluate the health benefits, costs, and cost-effectiveness of vaccination with bivalent respiratory syncytial virus stabilized prefusion F vaccine (RSVpreF) for the prevention of lower respiratory tract disease caused by respiratory...

Read More

Setting Treatment Selection Criteria for Breast Cancer From a Clinician Perspective: Is It a Matter of Cost?

Jan 4, 2024

Published on: Value in Health
Authors: George Gourzoulidis, Athanasios Balasopoulos, Efi Chaviara, Petros Savourdos, Charalampos Tzanetakos,

Abstract: OBJECTIVES: Several systemic therapeutic options are available for breast cancer(BC) and oncologists assess the appropriate regimen for each patient based on disease and treatment characteristics through major health budget constraints.The aim of the study...

Read More

Archive per Year